Literature DB >> 28026901

The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors.

Gwendolyn A Thomas1, Brenda Cartmel2, Maura Harrigan2, Martha Fiellin2, Scott Capozza2, Yang Zhou2, Elizabeth Ercolano2, Cary P Gross2, Dawn Hershman3, Jennifer Ligibel4, Kathryn Schmitz5, Fang-Yong Li2, Tara Sanft2, Melinda L Irwin2.   

Abstract

OBJECTIVE: This study examined the effect of 12 months of aerobic and resistance exercise versus usual care on changes in body composition in postmenopausal breast cancer survivors taking aromatase inhibitors (AIs).
METHODS: The Hormones and Physical Exercise study enrolled 121 breast cancer survivors and randomized them to either supervised twice-weekly resistance exercise training and 150 min/wk of aerobic exercise (N = 61) or a usual care (N = 60) group. Dual-energy X-ray absorptiometry scans were conducted at baseline, 6 months, and 12 months to assess changes in body mass index, percent body fat, lean body mass, and bone mineral density.
RESULTS: At 12 months, the exercise group relative to the usual care group had a significant increase in lean body mass (0.32 vs. -0.88 kg, P = 0.03), a decrease in percent body fat (-1.4% vs. 0.48%, P = 0.03), and a decrease in body mass index (-0.73 vs. 0.17 kg/m2 , P = 0.03). Change in bone mineral density was not significantly different between groups at 12 months (0.001 vs. -0.006 g/cm2 , P = 0.37).
CONCLUSIONS: A combined resistance and aerobic exercise intervention improved body composition in breast cancer survivors taking AIs. Exercise interventions may help to mitigate the negative side effects of AIs and improve health outcomes in breast cancer survivors.
© 2016 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28026901      PMCID: PMC5450163          DOI: 10.1002/oby.21729

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  36 in total

Review 1.  Nutrition and physical activity guidelines for cancer survivors.

Authors:  Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012-04-26       Impact factor: 508.702

2.  Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians.

Authors:  A M Kriska; W C Knowler; R E LaPorte; A L Drash; R R Wing; S N Blair; P H Bennett; L H Kuller
Journal:  Diabetes Care       Date:  1990-04       Impact factor: 19.112

3.  Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial.

Authors:  M E Nelson; M A Fiatarone; C M Morganti; I Trice; R A Greenberg; W J Evans
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

Review 4.  Cancer treatment-induced bone loss in breast and prostate cancer.

Authors:  Fred Saad; Jonathan D Adachi; Jacques P Brown; Leah A Canning; Karen A Gelmon; Robert G Josse; Kathleen I Pritchard
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

5.  Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study.

Authors:  Anne McTiernan; Charles Kooperberg; Emily White; Sara Wilcox; Ralph Coates; Lucile L Adams-Campbell; Nancy Woods; Judith Ockene
Journal:  JAMA       Date:  2003-09-10       Impact factor: 56.272

6.  Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer.

Authors:  R J Freedman; N Aziz; D Albanes; T Hartman; D Danforth; S Hill; N Sebring; J C Reynolds; J A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

7.  Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.

Authors:  Richard Eastell; Judith E Adams; Robert E Coleman; Anthony Howell; Rosemary A Hannon; Jack Cuzick; John R Mackey; Matthias W Beckmann; Glen Clack
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

8.  Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.

Authors:  Tiina Saarto; Leena Vehmanen; Carl Blomqvist; Inkeri Elomaa
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

9.  Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial.

Authors:  Luke J Peppone; Karen M Mustian; Michelle C Janelsins; Oxana G Palesh; Randy N Rosier; Kenneth M Piazza; Jason Q Purnell; Tom V Darling; Gary R Morrow
Journal:  Clin Breast Cancer       Date:  2010-06       Impact factor: 3.225

10.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.

Authors:  Robert Ross; Ian Janssen; Jody Dawson; Ann-Marie Kungl; Jennifer L Kuk; Suzy L Wong; Thanh-Binh Nguyen-Duy; SoJung Lee; Katherine Kilpatrick; Robert Hudson
Journal:  Obes Res       Date:  2004-05
View more
  21 in total

1.  High-intensity interval training can modulate the systemic inflammation and HSP70 in the breast cancer: a randomized control trial.

Authors:  Ali Mohammad Alizadeh; Amin Isanejad; Sanambar Sadighi; Mahtab Mardani; Bita Kalaghchi; Zuhair Mohammad Hassan
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-10       Impact factor: 4.553

Review 2.  The effects of exercise on the bone health of people with cancer: a systematic review and meta-analysis.

Authors:  Grace L Rose; Tina L Skinner; Shelley E Keating; Nina K Friedrich; Kate A Bolam
Journal:  Osteoporos Int       Date:  2021-09-17       Impact factor: 4.507

3.  The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis.

Authors:  J Dalla Via; R M Daly; S F Fraser
Journal:  Osteoporos Int       Date:  2017-10-02       Impact factor: 4.507

Review 4.  Clinical implications of low skeletal muscle mass in early-stage breast and colorectal cancer.

Authors:  Elizabeth Cespedes Feliciano; Wendy Y Chen
Journal:  Proc Nutr Soc       Date:  2018-06-04       Impact factor: 6.297

5.  Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

Authors:  Kate E Roberts; Kirsty Rickett; Sophie Feng; Dimitrios Vagenas; Natasha E Woodward
Journal:  Cochrane Database Syst Rev       Date:  2020-01-29

6.  Obese Breast Cancer Patients and Survivors: Management Considerations.

Authors:  Jennifer Y Sheng; Dipali Sharma; Gerald Jerome; Cesar Augusto Santa-Maria
Journal:  Oncology (Williston Park)       Date:  2018-08-15       Impact factor: 2.533

7.  Body weight management in overweight and obese breast cancer survivors.

Authors:  Hassan Shaikh; Peter Bradhurst; Li Xin Ma; Sim Yee Cindy Tan; Sam J Egger; Janette L Vardy
Journal:  Cochrane Database Syst Rev       Date:  2020-12-11

8.  Impact of Rowing Training on Quality of Life and Physical Activity Levels in Female Breast Cancer Survivors.

Authors:  Juan Gavala-González; Amanda Torres-Pérez; José Carlos Fernández-García
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

Review 9.  Interventions for promoting habitual exercise in people living with and beyond cancer.

Authors:  Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke
Journal:  Cochrane Database Syst Rev       Date:  2018-09-19

10.  Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.

Authors:  Christina M Dieli-Conwright; Kerry S Courneya; Wendy Demark-Wahnefried; Nathalie Sami; Kyuwan Lee; Frank C Sweeney; Christina Stewart; Thomas A Buchanan; Darcy Spicer; Debu Tripathy; Leslie Bernstein; Joanne E Mortimer
Journal:  Breast Cancer Res       Date:  2018-10-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.